Why it matters: Without lasting behavior changes and healthy habits, many GLP-1 users ultimately end up back where they started
Need a safer battery design
Clinical data shows 46 pounds lost for a 220 lb person
In four cancer types, the GLP-1 group was less likely to develop stage IV cancer: Lung cancer - 50% risk reduction Breast cancer - 43% risk reduction Liver cancer - 38% risk reduction Colorectal cancer - 31% risk reduction In the other three cancers - prostate, pancreatic and kidney - the GLP-1 group had fewer instances of stage IV disease, but the differences were not statistically significant
One injection a day, typically at bedtime to match the natural growth-hormone release cycle
Studies have found elevated levels of autoantibodies targeting key receptors, such as ACE2 (the primary receptor for SARS-CoV-2), 2-adrenoceptors, muscarinic M2 receptors, angiotensin II AT1 receptors, and angiotensin 17 MAS receptors [73,74,75]